Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Neurobehavioral Manifestations » Communication Disorders » Language Disorders » Speech Disorders » Aphasia
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Neurobehavioral Manifestations » Communication Disorders » Language Disorders » Speech Disorders » Aphasia
Description
A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia. MeSH
Hierarchy View
Subtype Terms (4)
Aphasia, Broca
2 approved drugs
Aphasia, Primary Progressive
6 drugs (5 approved, 1 experimental)
Phase 4 Indicated Drugs (3)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (2)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (4)
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
